{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T06:47:44Z","timestamp":1779346064574,"version":"3.51.4"},"reference-count":32,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,10]]},"DOI":"10.1097\/wco.0b013e32834a9448","type":"journal-article","created":{"date-parts":[[2011,8,6]],"date-time":"2011-08-06T09:32:54Z","timestamp":1312623174000},"page":"469-474","source":"Crossref","is-referenced-by-count":5,"title":["Motor neuron, nerve, and neuromuscular junction disease"],"prefix":"10.1097","volume":"24","author":[{"given":"Josef","family":"Finsterer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lea","family":"Papi\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michaela","family":"Auer-Grumbach","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-10-20210206","doi-asserted-by":"crossref","first-page":"e1002030","DOI":"10.1371\/journal.pgen.1002030","article-title":"Survival motor neuron protein regulates stem cell division, proliferation, and differentiation in Drosophila.","volume":"7","author":"Grice","year":"2011","journal-title":"PLoS Genet"},{"key":"R2-10-20210206","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.neuron.2010.12.032","article-title":"Early functional impairment of sensory-motor connectivity in a mouse model of spinal muscular atrophy.","volume":"69","author":"Mentis","year":"2011","journal-title":"Neuron"},{"key":"R4-10-20210206","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1097\/WNR.0b013e3283469615","article-title":"Directed differentiation of motor neuron cell-like cells from human adipose-derived stem cells in vitro.","volume":"22","author":"Liqing","year":"2011","journal-title":"Neuroreport"},{"key":"R5-10-20210206","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/1471-2202-12-25","article-title":"Proteomic assessment of a cell model of spinal muscular atrophy.","volume":"12","author":"Wu","year":"2011","journal-title":"BMC Neurosci"},{"key":"R6-10-20210206","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/1750-1326-6-24","article-title":"Generation and characterization of a genetic zebrafish model of SMA carrying the human SMN2 gene.","volume":"6","author":"Hao le T, Burghes","year":"2011","journal-title":"Mol Neurodegener"},{"key":"R7-10-20210206","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1136\/jmg.2010.080366","article-title":"Salbutamol increases survival motor neuron (SMN) transcript levels in leucocytes of spinal muscular atrophy (SMA) patients: relevance for clinical trial design.","volume":"47","author":"Tiziano","year":"2010","journal-title":"J Med Genet"},{"key":"R9-10-20210206","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1136\/jnnp.2010.236018","article-title":"Differential corticospinal tract degeneration in homozygous D90A SOD-1 ALS and sporadic ALS.","volume":"82","author":"Blain","year":"2011","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R10-10-20210206","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1002\/mus.21707","article-title":"Motor unit number index (MUNIX): a novel neurophysiological technique to follow disease progression in amyotrophic lateral sclerosis.","volume":"42","author":"Neuwirth","year":"2010","journal-title":"Muscle Nerve"},{"key":"R11-10-20210206","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/1471-2202-12-24","article-title":"Endosomal accumulation of APP in Wobbler motor neurons reflects impaired vesicle trafficking: implications for human motor neuron disease.","volume":"12","author":"Palmisano","year":"2011","journal-title":"BMC Neurosci"},{"key":"R12-10-20210206","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s13238-011-1525-0","article-title":"FUSTLS forms cytoplasmic aggregates, inhibits cell growth and interacts with TDP-43 in a yeast model of amyotrophic lateral sclerosis.","volume":"2","author":"Kryndushkin","year":"2011","journal-title":"Protein Cell"},{"key":"R13-10-20210206","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/j.neuron.2010.11.036","article-title":"Exome sequencing reveals VCP mutations as a cause of familial ALS.","volume":"68","author":"Johnson","year":"2010","journal-title":"Neuron"},{"key":"R14-10-20210206","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/S1474-4422(10)70197-6","article-title":"Chromosome 9p21 in sporadic amyotrophic lateral sclerosis in the UK and seven other countries: a genome-wide association study.","volume":"9","author":"Shatunov","year":"2010","journal-title":"Lancet Neurol"},{"issue":"Suppl A","key":"R15-10-20210206","first-page":"31","article-title":"Bone marrow stem cell transplantation in amyotrophic lateral sclerosis: technical aspects and preliminary results from a clinical trial.","volume":"32","author":"Blanquer","year":"2010","journal-title":"Methods Find Exp Clin Pharmacol"},{"key":"R16-10-20210206","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.neulet.2011.03.017","article-title":"Dual transplantation of human neural stem cells into cervical and lumbar cord ameliorates motor neuron disease in SOD1 transgenic rats.","volume":"494","author":"Xu","year":"2011","journal-title":"Neurosci Lett"},{"key":"R17-10-20210206","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1159\/000323718","article-title":"Vascular endothelial growth factor attenuates neurodegenerative changes in the NSC-34 motor neuron cell line induced by cerebrospinal fluid of sporadic amyotrophic lateral sclerosis patients.","volume":"8","author":"Kulshreshtha","year":"2011","journal-title":"Neurodegener Dis"},{"key":"R18-10-20210206","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/1750-1326-6-26","article-title":"A mutation in the dynein heavy chain gene compensates for energy deficit of mutant SOD1 mice and increases potentially neuroprotective IGF-1.","volume":"6","author":"Fergani","year":"2011","journal-title":"Mol Neurodegener"},{"key":"R19-10-20210206","doi-asserted-by":"crossref","first-page":"e130","DOI":"10.1038\/cddis.2011.11","article-title":"Enhanced neuronal Met signalling levels in ALS mice delay disease onset.","volume":"2","author":"Genestine","year":"2011","journal-title":"Cell Death Dis"},{"key":"R20-10-20210206","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1159\/000323469","article-title":"Prevention of motor neuron degeneration by novel iron chelators in SOD1G93A transgenic mice of amyotrophic lateral sclerosis.","volume":"8","author":"Wang","year":"2011","journal-title":"Neurodegener Dis"},{"key":"R21-10-20210206","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/S1474-4422(10)70182-4","article-title":"Japan SBMA Interventional Trial for TAP-144-SR (JASMITT) study group. Efficacy and safety of leuprorelin in patients with spinal and bulbar muscular atrophy (JASMITT study): a multicentre, randomised, double-blind, placebo-controlled trial.","volume":"9","author":"Katsuno","year":"2010","journal-title":"Lancet Neurol"},{"key":"R22-10-20210206","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1136\/jnnp.2008.158295","article-title":"Diagnosis and new treatments in genetic neuropathies.","volume":"80","author":"Reilly","year":"2009","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R23-10-20210206","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1097\/00019052-200310000-00008","article-title":"Hereditary neuropathies.","volume":"16","author":"Berciano","year":"2003","journal-title":"Curr Opin Neurol"},{"key":"R24-10-20210206","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1002\/ana.22166","article-title":"Charcot-Marie-Tooth disease subtypes and genetic testing strategies.","volume":"69","author":"Saporta","year":"2011","journal-title":"Ann Neurol"},{"key":"R25-10-20210206","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1007\/s00415-003-1030-3","article-title":"Diagnosis of hereditary neuropathies in adult patients.","volume":"250","author":"Pareyson","year":"2003","journal-title":"J Neurol"},{"key":"R26-10-20210206","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1007\/s11940-011-0115-z","article-title":"Inherited neuropathies.","volume":"13","author":"Schenone","year":"2011","journal-title":"Curr Treat Options Neurol"},{"key":"R27-10-20210206","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1097\/WCO.0b013e3283394203","article-title":"Investigations and treatment of chronic inflammatory demyelinating polyradiculoneuropathy and other inflammatory demyelinating polyneuropathies.","volume":"23","author":"Tracy","year":"2010","journal-title":"Curr Opin Neurol"},{"key":"R28-10-20210206","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1136\/jnnp.2009.188912","article-title":"Rituximab in patients with chronic inflammatory demyelinating polyradiculoneuropathy: a report of 13 cases and review of the literature.","volume":"82","author":"Benedetti","year":"2011","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R31-10-20210206","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1002\/ana.22312","article-title":"Autoantibodies to low-density lipoprotein receptor-related protein 4 in myasthenia gravis.","volume":"69","author":"Higuchi","year":"2011","journal-title":"Ann Neurol"},{"key":"R32-10-20210206","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1200\/JCO.2010.32.0440","article-title":"Clinical Dutch-English Lambert-Eaton Myasthenic syndrome (LEMS) tumor association prediction score accurately predicts small-cell lung cancer in the LEMS.","volume":"29","author":"Titulaer","year":"2011","journal-title":"J Clin Oncol"},{"key":"R33-10-20210206","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.ajhg.2011.01.008","article-title":"Hexosamine biosynthetic pathway mutations cause neuromuscular transmission defect.","volume":"88","author":"Senderek","year":"2011","journal-title":"Am J Hum Genet"},{"key":"R34-10-20210206","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.molcel.2010.06.007","article-title":"The cytoplasmic adaptor protein Dok7 activates the receptor tyrosine kinase MuSK via dimerization.","volume":"39","author":"Bergamin","year":"2010","journal-title":"Mol Cell"},{"key":"R35-10-20210206","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.1093\/hmg\/ddq110","article-title":"Mutations in MUSK causing congenital myasthenic syndrome impair MuSK-Dok-7 interaction.","volume":"19","author":"Maselli","year":"2010","journal-title":"Hum Mol Genet"},{"key":"R36-10-20210206","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1212\/WNL.0b013e3181dd43bf","article-title":"Ephedrine treatment in congenital myasthenic syndrome due to mutations in DOK7.","volume":"74","author":"Lashley","year":"2010","journal-title":"Neurology"}],"container-title":["Current Opinion in Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/WCO.0b013e32834a9448","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T08:11:12Z","timestamp":1620979872000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00019052-201110000-00010"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,10]]},"references-count":32,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.1097\/wco.0b013e32834a9448","relation":{},"ISSN":["1350-7540"],"issn-type":[{"value":"1350-7540","type":"print"}],"subject":[],"published":{"date-parts":[[2011,10]]}}}